Skip Main Navigation
Page Content

Translational Research Institute (TRI)

TRI is a ground breaking, industry leading initiative in the Australian medical research field.

As a ‘think tank’ of collaborative minds, TRI joins the future direction of medical research. 

TRI is the largest medical research institutes in the southern hemisphere. 

Its ‘bench to bedside’ model will enable collaborative research in which new treatments can be developed and tested by establishing and modelling the genetic and environmental basis of human disease.
TRI represents a unique collaboration of our four research partners: The University of Queensland Diamantina Institute (UQDI), Queensland University of Technology Institute of Health and Biomedical Innovation (IBHI), Mater Research, and Princess Alexandra Hospital Centres for Health Research (CHR), along with its health partner, Patheon Biologics. 
Led by Professor Carolyn Mountford as CEO and Director of Research and Professor Ian Frazer, Chair of the TRI Foundation, TRI is the bringing together of the best and brightest minds to exchange ideas and work that ultimately translates to life-changing therapeutics and treatments.
Connect with us
Facebook icon  LinkedIn logo Youtube Icon